Thymidylate synthase: A target for anticancer drug design
- 1 January 1989
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 29, 161-179
- https://doi.org/10.1016/0065-2571(89)90099-x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Polyglutamation of methotrexate. Is methotrexate a prodrug?Journal of Clinical Investigation, 1985
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in micePublished by Elsevier ,1981
- Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidinesChemico-Biological Interactions, 1977
- Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductasePublished by Elsevier ,1977
- Factors determining cell sensitivity to methotrexate: Studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell linesPublished by Elsevier ,1974
- Studies with a mathematical model of folate metabolismArchives of Biochemistry and Biophysics, 1973
- SITES OF ACTION OF AMETHOPTERIN: INTRINSIC AND ACQUIRED DRUG RESISTANCEAnnals of the New York Academy of Sciences, 1971
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cellsBiochemical Pharmacology, 1962
- Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cellsBiochemical Pharmacology, 1961